Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name HMlincRNA717
   Synonyms HMlincRNA717, GACAT2, MTCL1-AS1, MTCL1AS1, GACAT2
   Region GRCh38_18:8695856-8707621    Sequence
   Ensembl ENSG00000265962
   RefSeq NR_120598
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name non small cell lung cancer
   ICD-0-3 C34  M8046/3
   Methods qPCR etc.
   Sample NSCLC tissues, cell lines (A549, H157, HEK-293T)
   Expression Pattern down-regulated
   Function Description

lncRNA HMlincRNA717 expression level was significantly decreased in NSCLC tissues in comparison to adjacent non-tumor tissues. It was also proved that HMlincRNA717 expression was to be associated with NSCLC histological grade, and lymph node metastasis. In addition, survival analysis proved that down-regulated HMlincRNA717 expression was associated with poor overall survival of NSCLC patients. HMlincRNA717 expression was an independent prognostic factor for patients with NSCLC, which might be a potential prognostic biomarker and therapeutic target for NSCLC.

   Pubmed ID 25674259
   Year 2015
   Title LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
   External Links
   Links for  HMlincRNA717 GenBank       HGNC       lncrnadb       Noncode
   Links for  non small cell lung cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.